12.63
전일 마감가:
$12.28
열려 있는:
$12.42
하루 거래량:
599.30K
Relative Volume:
1.09
시가총액:
$557.81M
수익:
$200.93M
순이익/손실:
$-18.91M
주가수익비율:
-28.58
EPS:
-0.4419
순현금흐름:
$-9.09M
1주 성능:
-4.10%
1개월 성능:
-18.62%
6개월 성능:
-14.20%
1년 성능:
-9.98%
Si Bone Inc Stock (SIBN) Company Profile
명칭
Si Bone Inc
전화
(408) 207-0700
주소
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
SIBN
Si Bone Inc
|
12.63 | 542.35M | 200.93M | -18.91M | -9.09M | -0.4419 |
|
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-27 | 개시 | TD Cowen | Buy |
| 2024-08-06 | 재확인 | Needham | Buy |
| 2024-03-28 | 개시 | Piper Sandler | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-04-07 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-06-08 | 개시 | Citigroup | Buy |
| 2021-03-09 | 재확인 | Needham | Buy |
| 2020-12-16 | 재확인 | Needham | Buy |
| 2020-08-04 | 재확인 | Needham | Buy |
| 2020-06-16 | 재개 | Cantor Fitzgerald | Overweight |
| 2020-05-05 | 재확인 | Needham | Buy |
| 2020-02-19 | 개시 | Needham | Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-12-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-11-12 | 개시 | BofA/Merrill | Buy |
| 2018-11-12 | 개시 | Canaccord Genuity | Buy |
| 2018-11-12 | 개시 | JMP Securities | Mkt Outperform |
| 2018-11-12 | 개시 | Morgan Stanley | Overweight |
모두보기
Si Bone Inc 주식(SIBN)의 최신 뉴스
SI-BONE Inc Stock: Innovating Sacroiliac Joint Fusion in a Competitive Medtech Landscape - AD HOC NEWS
SiBone (NASDAQ:SIBN) Sees Large Growth in Short Interest - MarketBeat
SI-BONE raises 2025 revenue guidance to $195M-$198M with accelerated cash flow milestones - MSN
SiBone (NASDAQ:SIBN) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Vanguard files 13G/A showing 0 shares in SI-BONE (SIBN) - Stock Titan
SiBone (NASDAQ:SIBN) Sets New 12-Month LowWhat's Next? - MarketBeat
Aug PostEarnings: What is the next catalyst for SI BONE Inc2026 Big Picture & Real-Time Buy Signal Notifications - baoquankhu1.vn
Piper Sandler reiterates SI-BONE stock rating on growth outlook By Investing.com - Investing.com Australia
Piper Sandler reiterates SI-BONE stock rating on growth outlook - Investing.com
Jim Cramer on SI-BONE, Inc.: "We're not going to buy the money losers" - MSN
(SIBN) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Stop Loss: Is SI BONE Inc stock showing strong momentumQuarterly Growth Report & Safe Entry Momentum Tips - baoquankhu1.vn
S P Trends: Is SI BONE Inc stock showing strong momentumQuarterly Market Review & Real-Time Volume Triggers - baoquankhu1.vn
SI-BONE outlines 14%-16% revenue growth for 2026 with new product launches and Smith & Nephew partnership - MSN
Granahan Investment Management LLC Sells 224,678 Shares of SiBone $SIBN - MarketBeat
SiBone $SIBN Shares Purchased by First Light Asset Management LLC - MarketBeat
Divisadero Street Capital Management LP Trims Holdings in SiBone $SIBN - MarketBeat
Nishimura Mika, Si-Bone director, sells $56k in SIBN stock - Investing.com
SiBone (NASDAQ:SIBN) Director Mika Nishimura Sells 4,100 Shares - MarketBeat
Insider Sell: Mika Nishimura Sells 4,100 Shares of SI-BONE Inc (SIBN) - GuruFocus
[Form 4] SI-BONE, Inc. Insider Trading Activity - Stock Titan
Jim Cramer on SI-BONE, Inc.: “We’re Not Going to Buy the Money Losers” - Insider Monkey
[144] SI-BONE, Inc. SEC Filing - Stock Titan
SiBone (NASDAQ:SIBN) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Liquidity Mapping Around (SIBN) Price Events - Stock Traders Daily
Jim Cramer on SI-BONE: "This is a great, great speculation" - MSN
American Century Companies Inc. Acquires 521,683 Shares of SiBone $SIBN - MarketBeat
Earnings Recap: Can SI BONE Inc disrupt its industryGap Up & Trade Opportunity Analysis Reports - baoquankhu1.vn
Will SI BONE Inc. stock deliver strong dividend growthJuly 2025 Chart Watch & High Win Rate Trade Tips - Naître et grandir
SIBN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
First Eagle Investment Management LLC Has $7.13 Million Stock Position in SiBone $SIBN - MarketBeat
Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026 - GlobeNewswire Inc.
SIBN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Si-Bone at TD Cowen Health Care Conference: Strategic Growth Plans - Investing.com
SIBN PE Ratio & Valuation, Is SIBN Overvalued - Intellectia AI
SIBN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
SIBN SEC FilingsSi-Bone 10-K, 10-Q, 8-K Forms - Stock Titan
Why (SIBN) Price Action Is Critical for Tactical Trading - Stock Traders Daily
SI-BONE, Inc. (SIBN) Stock Analysis: Strong Buy Ratings Signal 57.73% Potential Upside - DirectorsTalk Interviews
Smith+Nephew signs distribution agreement with SI-BONE - MedTech Intelligence
Aug Technicals: What is the next catalyst for SI BONE Inc2025 Year in Review & Growth Focused Entry Reports - baoquankhu1.vn
Spartan Medical Inc. and SI-BONE Inc. Proudly Announce New Partne - The National Law Review
Spartan Medical Inc. and SI-BONE Inc. Proudly Announce New Partnership to Expand Access For Veterans & Wounded Warriors - EIN Presswire
SI‑BONE (SIBN) Losses Narrow In Q4 And Test Bearish Narratives On Profit Path - simplywall.st
SI-BONE, Inc. (NASDAQ:SIBN) Q4 2025 Earnings Call Transcript - Insider Monkey
SI-Bone (SIBN) Submits Automatic Mixed Securities Shelf Filing - GuruFocus
Si-Bone files for mixed shelf size not disclosed - marketscreener.com
Si-Bone Files For Mixed Shelf Size Not Disclosed - TradingView
Si-Bone inks 50,000-square-foot lease in San Jose - The Business Journals
Si Bone Inc (SIBN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):